Stay updated on Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a visible 'Study Status' section to the record history (dated 2025-12-22) and updated the site revision to v3.3.3. The HHS Vulnerability Disclosure link was removed in a prior update (2024-11-22).SummaryDifference0.7%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedNew revision entry v3.3.2 added and v3.3.1 removed, reflecting an administrative release-note update to the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 from the study record history.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved the notice about a lapse in government funding and potential data delays. The notice previously warned that information may not be up to date and directed users to cc.nih.gov and opm.gov for operating status.SummaryDifference0.8%

- Check66 days agoChange DetectedA new version entry updates the study's recruitment status and overall study status in the Record History.SummaryDifference0.1%

- Check95 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.